EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 03 May 2024. Database contains 4691 unique substances/entries.

Filter the list

Showing 4,001 - 4,200 of 4,691 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)
lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-) ACID RED FC 70013	414-250-7	149564-66-9	Acute Tox. 4; Eye Dam. 1
lithium sodium 4,4', 4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate	429-730-1	193562-37-7	Eye Dam. 1; Skin Sens. 1
lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate REACTIVE BLUE FC 05 717	401-560-2	108624-00-6	Skin Sens. 1
lufenuron (ISO); N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide CGA 184699	410-690-9	103055-07-8	Skin Sens. 1
m-mentha-1,3(8)-diene PRODUCT 5899	404-150-1	17092-80-7	Skin Irrit. 2
magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate) DUPLOSAN-DP-MAGNESIUM	413-360-2	164058-21-3	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
magnesium sodium fluoride silicate	442-650-1	56450-90-9	STOT RE 2
main component 1 (isomer 1):; 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 1 (isomer 2):; 2-{6-fluoro-4-[3-(2,5-disulfophenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt	422-610-1	-	Eye Dam. 1
main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol; main component 8 (isomer):; asym. 1:2 Cr-complex of: A:; 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol BLACK UL 1253	417-280-9	30785-74-1	Eye Dam. 1
Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III); by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfonyl)-3''-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III); by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III) BLACK JR 578	419-230-1	-	Skin Sens. 1
mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine	432-140-7	110235-47-7	Carc. 2
methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate GR138766X	415-670-3	78850-37-0	Eye Dam. 1
methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate	445-990-9	376588-17-9	Skin Sens. 1
methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate HALOXYFOP R-(+)-ME HERBICIDAL CHEMICAL	406-250-0	72619-32-0	Acute Tox. 4
methyl (R)-2-(4-hydroxyphenoxy)propionate DHPPME; MAK-ME; MEHPOPS; R-MAQ-ME	411-950-4	96562-58-2	Eye Dam. 1
methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate	432-350-9	81752-87-6	Skin Irrit. 2
methyl 2-(2-nitrobenzylidene)acetoacetate 2-NITROBENZYLIDENE METHYL ESTER; BAY O 2787	400-650-9	39562-27-1	Skin Sens. 1
methyl 2-(3-nitrobenzylidene)acetoacetate BM	405-270-7	39562-17-9	Skin Sens. 1
methyl 2-(acetylamino)-3-chloropropionate	442-860-3	87333-22-0	Skin Sens. 1
methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate DISPERSE RED CLA 282	416-240-8	155522-12-6	Skin Sens. 1
methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate JE 127	421-220-7	144740-59-0	Skin Sens. 1
methyl 2-benzylidene-3-oxobutyrate LUGALVAN ES 9571	420-940-9	15768-07-7	Eye Irrit. 2; Skin Irrit. 2
methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate	443-120-2	393509-79-0	Eye Dam. 1
methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate MEFAT	404-130-2	105560-93-8	Eye Dam. 1; Skin Sens. 1
methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate G 18-1108	403-270-1	6386-39-6	Acute Tox. 4
methyl 3-(acetylthio)-2-methyl-propanoate D,L-ESTER	411-040-7	97101-46-7	Acute Tox. 4; Skin Sens. 1
methyl 3-amino-2,2,3-trimethylbutyrate	431-720-7	90886-53-6	Skin Corr. 1B; Acute Tox. 4
methyl 3-amino-4,6-dibromo-2-methyl-benzoate	425-190-6	119916-05-1	STOT RE 2
methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate F7641; MTSI	410-550-7	79277-18-2	STOT RE 2; Resp. Sens. 1; Skin Sens. 1
methyl 3-sulphamoyl-2-thenoate A5546	402-050-2	59337-93-8	Skin Sens. 1
methyl 4-bromomethyl-3-methoxybenzoate BROMBENZOAT; BROMOBENZOATE	410-310-1	70264-94-7	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate MAT 9460	414-080-3	117291-73-3	Acute Tox. 4
methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide) MAGME(R) 200 MONOMER	403-230-3	77402-05-2	Carc. 1B; Muta. 1B; Skin Corr. 1B; Skin Sens. 1
methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid) MAGME 100 MONOMEER	401-890-7	77402-03-0	Carc. 1B; Muta. 1B; Acute Tox. 4; Eye Irrit. 2
methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate FAT 40'489	413-040-2	149850-30-6	Skin Sens. 1
methyl neodecanamide	414-460-9	105726-67-8	Acute Tox. 4
methyl tetrahydro-2-furancarboxylate METHFAT	420-670-1	37443-42-8	Eye Dam. 1
methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate F5384	401-340-6	83055-99-6	Skin Sens. 1
methyl-2-[(aminosulfonyl)methyl]benzoate N 5297	419-010-5	112941-26-1	Acute Tox. 4; Eye Irrit. 2
methyl-3-methoxyacrylate BETA-METHOXYACRYLSÄURE METHYLESTER	412-900-4	5788-17-0	Skin Sens. 1
methyl-5-nitrophenyl-guanidine	435-500-1	152460-07-6	Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
methylethylketone peroxide trimer	429-320-2	24748-23-0	Org. Perox. B; Asp. Tox. 1; Skin Irrit. 2; Skin Sens. 1
methyltriphenylphosphonium chloride METHYL-TPP-CHLORID; MTPP-CHLORID	418-400-2	1031-15-8	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
metosulam (ISO); N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a] pyrimidine-2-sulfonamide	410-240-1	139528-85-1	Carc. 2; STOT RE 2
mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin NUPORE G45-10	420-480-9	158570-99-1	Skin Irrit. 2; Skin Sens. 1
mono-2-[2-(4-dibenzo[b, f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate ICI204636 HYDROGEN FUMARATE	415-180-1	773058-82-5	Acute Tox. 4; Eye Dam. 1
mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate Z-22	415-880-5	779343-34-9	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate	429-570-2	213990-58-0	Skin Sens. 1
myclobutanil(ISO);2-(4-chlorophenyl)-2-(1H-1,2,4- triazol-1-ylmethyl)hexanenitrile SYSTHANE TECHNICAL	410-400-0	88671-89-0	Repr. 2; Acute Tox. 4; Eye Irrit. 2
N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide	435-860-1	214417-91-1	Skin Sens. 1
N, N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]	429-380-1	133336-92-2	Skin Sens. 1
N, N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea	430-930-6	122886-55-9	Eye Dam. 1; Resp. Sens. 1
N, N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine	435-010-8	26157-73-3	Muta. 2
N, N'-(2,2-dimethylpropylidene)hexamethylenediamine LUPRAGEN VP 9159	401-660-6	1000-78-8	Skin Irrit. 2; Skin Sens. 1
N, N'-bis(trifluoroacetyl)-S, S'-bis-L-homocysteine BMS 208143-01; BTHC	429-670-6	105996-54-1	Eye Dam. 1; Skin Sens. 1
N, N'-ethylenebis(vinylsulfonylacetamide) H-603	404-790-1	66710-66-5	Eye Dam. 1; Skin Sens. 1
N, N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate CARTASOL BRILLIANT YELLOW K-6G; CARTASOL BRILLIANT YELLOW K-6G CONC.; GIALLO BRILLANTE CARTASOL K-6G CONC.; JAUNE BRILLANT CARTASOL K-RWA 3904; RWA 3904	403-340-1	164578-09-0	Eye Dam. 1
N, N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride AF-172; FPC 114	405-300-9	17339-60-5	Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
N, N-(dimethylamino)thioacetamide hydrochloride	435-470-1	27366-72-9	Repr. 1B
N, N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide DIETHANOLAMIN-TRITOSYLAT	412-920-3	16695-22-0	Skin Sens. 1
N, N-bis(2-ethylhexyl)-((1,2,4- triazol-1-yl)methyl)amine CM 23-376; REOMET 30	401-280-0	91273-04-0	Skin Corr. 1B; Skin Sens. 1
N, N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane	445-890-5	201290-01-9	Acute Tox. 4; Skin Sens. 1
N, N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide	418-290-6	168612-06-4	Eye Irrit. 2; Skin Sens. 1
N, N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine DDPD	406-610-7	62478-82-4	Flam. Liq. 3; Acute Tox. 4; STOT RE 2; Skin Corr. 1A
N, N-dimethyl-2-(3-(4-chloro phenyl)-4,5-dihydropyrazol-1- ylphenylsulphonyl)ethylamine HOSTALUX VP 3481	401-410-6	10357-99-0	STOT RE 2; Skin Sens. 1
N, N-dimethylanilinium tetrakis(pentafluorophenyl)borate B1; N,N-DIMETHYLANILINUM TETRAKIS(PENTAFLUOROPHENYL)BORATE; TÉTRAKIS(PENTAFLUOROPHÉNYL)BORATE DE N,N-DIMÉTHYLANILINIUM	422-050-6	118612-00-3	Carc. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
N, N-hydrazinodiacetic acid F.H.D.A.	403-510-5	19247-05-3	Acute Tox. 3; STOT RE 2; Skin Sens. 1
N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide NYLOSTAB S-EED; NYSEED	419-710-0	42774-15-2	Acute Tox. 4; Eye Irrit. 2
N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt RED REN 363	419-500-9	171599-85-2	Eye Dam. 1; Skin Sens. 1
N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide QUESTAMIDE H	422-560-9	149591-38-8	Repr. 2; Eye Irrit. 2
N,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide LICHTSCHUTZMITTEL 1736	413-610-0	124172-53-8	Eye Irrit. 2
N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane PFMT 1848	410-060-3	130728-76-6	Muta. 2; Skin Sens. 1
N,N,N,N-tetrakis(4,6-bis(butyl- (N-methyl-2,2,6,6-tetramethyl piperidin-4-yl)amino)triazin-2- yl)-4,7-diazadecane-1,10- diamine CHIMASSORB 119; LOWILITE 19	401-990-0	106990-43-6	Skin Sens. 1
N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide	431-530-4	1380226-29-8	Skin Corr. 1A; Skin Sens. 1
N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine	429-640-2	52870-46-9	Eye Irrit. 2
N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride PPX-HCL	417-950-0	65797-42-4	Acute Tox. 4
N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide; (4-acetamido-2,2,6,6-tetra; methyl-1-piperidinyl)oxidanyl	423-840-3	14691-89-5	Acute Tox. 4
N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide UM-229	407-070-5	142859-67-4	Skin Sens. 1
N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide	425-650-6	171887-03-9	Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
N-(2-nitrophenyl)phosphoric triamide	477-690-9	874819-71-3	Repr. 1B; STOT RE 2
N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide UC-129	403-790-9	108673-51-4	Skin Sens. 1
N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide TSD-40	413-200-1	129604-78-0	Skin Sens. 1
N-(n-octyl)-2-pyrrolidone NOP; SURFADONE LP-100 SURFACTANT	403-700-8	2687-94-7	Skin Corr. 1B
N-[(benzotriazole-1-yl)methyl)]4-carboxy-benzenesulfonamide BTAD	416-470-9	170292-97-4	Eye Irrit. 2
N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-N-carboxyanhydride	430-360-8	84793-24-8	Eye Dam. 1; Skin Sens. 1
N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide DISPERSOL BLUE C-4G COLOUR; SUBSTANCE H87919	416-860-9	777891-21-1	Repr. 2; Skin Sens. 1
N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate DS 100	415-060-7	1379678-87-1	Eye Dam. 1; Skin Sens. 1
N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide	423-530-8	152828-23-4	STOT RE 1; Acute Tox. 4
N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide BENZANILID-DISPERSE-INTERMEDIATE ZP 9955	411-590-8	70693-57-1	Skin Corr. 1B
N-[4-cyano-3-trifluoromethylphenyl]methacrylamide	427-880-2	90357-53-2	STOT RE 2
N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide	424-550-1	84245-12-5	Carc. 1B; Muta. 1B; Repr. 1B
N-amidino-N-methylglycine-2-oxopropionate	429-120-5	208535-04-0	Eye Dam. 1
N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine	425-300-2	186450-73-7	Skin Sens. 1
N-butyl-2-(4-morpholinylcarbonyl)benzamide EP 389	407-730-2	104958-67-0	Eye Irrit. 2; Skin Sens. 1
N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide DISPERSOL YELLOW XF	407-970-8	75511-91-0	Skin Sens. 1
N-cyclohexyl-S, S-dioxo; benzo[b]tiophene-2-carboxamide PREVENTOL VP OC 3061	423-990-1	149118-66-1	Acute Tox. 4; Eye Dam. 1
N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate DIMETHYLPAPAMIDOLAURDIMONIUM TOSYLATE	421-130-8	156679-41-3	Eye Dam. 1; Skin Sens. 1
N-ethyl-3-trimethoxysilyl-2-methyl-propanamine	437-720-3	227085-51-0	Eye Dam. 1
N-ethyl-N-methylpiperidinium iodide CATALYST 4017	407-780-5	4186-71-4	Acute Tox. 4
N-hexadecyl(or octadecyl)-N-hexadecyl (or octadecyl)benzamide DTBA	401-980-6	-	Skin Irrit. 2; Skin Sens. 1
n-hexyllithium N-HEXYLLITHIUM	404-950-0	21369-64-2	Water-react. 1; Pyr. Sol. 1; Skin Corr. 1A
N-methyl-4-(p-formylstyryl)pyridinium methylsulfate N-METHYL-4-(P-FORMYLSTYRYL)-PYRIDINIUM METHYLSULFATE; SBQ; SBQ-SALZ	418-240-3	74401-04-0	Skin Sens. 1
N-methyl-N-cyanomethylmorpholiniummethylsulfate	429-340-1	186295-11-4	Acute Tox. 4; Eye Dam. 1
N-methylbenzene-1,2-diammonium hydrogen phosphate	424-460-0	283167-56-6	Acute Tox. 4; Skin Sens. 1
N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine	431-060-1	153719-38-1	Acute Tox. 4; Skin Sens. 1
N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine	426-150-0	121246-28-4	Skin Sens. 1
nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate DABCO X-412	413-670-8	103969-79-5	Eye Irrit. 2; Skin Sens. 1
N—tert-pentyl-2-benzothiazolesulfenamide VULKANISATIONSBESCHLEUNIGER VP KA 9124	404-380-2	110799-28-5	Skin Sens. 1
O, O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime] ASIL-322; OS-5200	421-870-1	156145-66-3	Repr. 2; Acute Tox. 4; STOT RE 2
O, O-tert-butyl O-docosyl monoperoxyoxalate KENODOX	404-300-6	116753-76-5	Org. Perox. C
O-ethylhydroxylamine ETA; ETA 50 (50 %IGE ZUBEREITUNG); O-ETHYLHYDROXYLAMINE	402-030-3	624-86-2	Flam. Liq. 2; Acute Tox. 3; STOT RE 1; Eye Irrit. 2; Skin Sens. 1
O-hexyl-N-ethoxycarbonylthiocarbamate	432-750-3	109202-58-6	Carc. 1B; Muta. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1
O-isobutyl-N-ethoxy carbonylthiocarbamate	434-350-4	103122-66-3	Flam. Liq. 3; Carc. 1B; Muta. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1
octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate PROCION BRILLIANT ORANGE H-EXL; S156745	412-960-1	148878-21-1	Eye Dam. 1; Skin Sens. 1
octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate H112339	413-550-5	-	Skin Irrit. 2; Eye Dam. 1
oxiranemethanol, 4-methylbenzene-sulfonate, (S)- DAISO CCS-1S-E; S-GLYTO	417-210-7	70987-78-9	Carc. 1B; Muta. 2; Eye Dam. 1; Skin Sens. 1
oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide LUCHEM HA-R 100; LUPERSOL HA-R 100	413-230-5	122035-71-6	Eye Dam. 1; Skin Sens. 1
p-tolyl 4-chlorobenzoate UP 565	411-530-0	15024-10-9	Skin Sens. 1
pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid	426-590-3	187412-41-5	Skin Sens. 1
pentapotassium 2,2',2'',2''',2''''-(ethane-1,2-diylnitrilo)pentaacetate	404-290-3	7216-95-7	Repr. 1B; Acute Tox. 4; STOT RE 2; Eye Irrit. 2
pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1yl)benzene-1,4-disulfonate	418-270-7	-	Skin Sens. 1
pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate REACTIVE NAVY BLUE 9411; SUMIFIX SUPRA MARINE BNF GRANULES	423-790-2	1379676-74-0	Eye Dam. 1; Skin Sens. 1
pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate	436-920-8	172399-10-9	Eye Dam. 1
pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) OLIVE-GREEN JB 1170	419-210-2	178452-71-6	Eye Dam. 1
pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate	414-910-4	-	Eye Dam. 1; Skin Sens. 1
pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid	442-030-0	321912-47-4	Eye Dam. 1
phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide CGI 819	423-340-5	162881-26-7	Skin Sens. 1A
phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate DPX-E6758	406-600-2	89392-03-0	Skin Sens. 1
platinum(IV) nitrate/nitric acid solution	432-400-1	10102-09-7	Skin Corr. 1A
poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium) AOC 2050X	403-430-0	138360-92-6	Eye Dam. 1
poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate BIOPOL HX	403-300-3	127536-43-0	Skin Sens. 1
poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride) RX-33	419-590-1	-	Flam. Sol. 1; Skin Sens. 1
poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]	427-480-8	176429-22-4	STOT SE 3; Skin Irrit. 2; Eye Dam. 1
poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]	427-280-0	176429-27-9	STOT SE 3; Skin Irrit. 2; Eye Dam. 1
polymer of allylamine hydrochloride PAA HCL; PAA HCL 10L; PAA HCL 10S; PAA HCL 3L; PAA HCL 3S; PAA HCL H; PAA HCL L	415-050-2	71550-12-4	Acute Tox. 4; Skin Sens. 1
polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N, N-di-2-propenylformamide X4060	404-035-6	1379801-27-0	Skin Sens. 1
potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate [containing < 0,5 % N, N-dimethylformamide (EC no; 200-679-5)];potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate [containing ≥ 0,5 % N, N-dimethylformamide (EC No 200-679-5)]	418-260-2	183196-57-8	Skin Sens. 1
potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate [containing < 0,5 % N, N-dimethylformamide (EC no; 200-679-5)];potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate [containing ≥ 0,5 % N, N-dimethylformamide (EC No 200-679-5)]	418-260-2	183196-57-8	Repr. 1B; Skin Sens. 1
potassium 2,5-dichlorobenzoate POTASSIUM 2,5-DICHLOROBENZOATE	415-700-5	184637-62-5	Acute Tox. 4; Eye Dam. 1
potassium 2-(2,4-dichlorophenoxy)-(R)-propionate DUPLOSAN-DP-KALIUM	413-580-9	113963-87-4	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
potassium 2-amino-2-methylpropionate octahydrate FLEXSORB HP SOLID; MALINE K	405-560-3	120447-91-8	Acute Tox. 4; Skin Corr. 1A
potassium 2-chloro-3-(benzyloxy)propionate KLOBENPROP	426-350-8	138666-92-9	Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1
potassium 2-hydroxycarbazole-1-carboxylate AZYLACID-POTASSIUMSALT	401-630-2	96566-70-0	Acute Tox. 4; Eye Irrit. 2; STOT SE 3
potassium 3-iodo-6-methylbenzenesulfonate	426-300-5	-	Eye Dam. 1
potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate V67282	406-500-9	174393-75-0	Skin Sens. 1
potassium 4-iodo-2-sulfonato-benzoic acid	426-620-5	619297-89-1	Eye Dam. 1
potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N, O,O, N)-ferrate-(1-)monohydrate CHEMICAL CHELATING AGENT #2	411-640-9	153352-59-1	Acute Tox. 4
potassium ferrite	430-010-4	12160-44-0	Skin Corr. 1B; Skin Sens. 1
potassium iron(III) 1,3-propanediamine-N, N,N',N'-tetraacetate hemihydrate FEKPDTA; KFEPDTA	405-680-6	148434-01-9	Self-heat. 2
potassium mu-fluoro-bis(triethylaluminium) EURELYT	400-040-2	12091-08-6	Flam. Sol. 1; Water-react. 1; Skin Corr. 1A; Acute Tox. 4
potassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate D(-) VALINE DANE SALT	427-240-2	134841-35-3	Skin Sens. 1
potassium N-(4-fluorophenyl)glycinate POTASSIUM N-(4-FLUOROPHENYL)GLYCINATE	415-710-1	184637-63-6	STOT RE 2; Eye Dam. 1; Skin Sens. 1
potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide POTASSIUM-P-TOLYLSULFIMIDE	406-650-5	97888-41-0	Eye Dam. 1
potassium sodium 3,3'-(3(or 4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate C.I. REACTIVE YELLOW 138:1	403-810-6	140876-13-7	Eye Dam. 1
potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate REAKTIVROT 2713	412-490-7	-	Skin Sens. 1
potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat C.I. REACTIVE RED 231	402-150-6	-	Eye Irrit. 2; Skin Sens. 1
potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate SUMIFIX BRILLIANTBLAU GL KONZENTRAT	414-100-0	154336-20-6	Eye Dam. 1
potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)	425-830-4	-	Eye Dam. 1
Potassium titanium oxide(K2Ti6O13)	432-240-0	12056-51-8	Carc. 2
potassium, sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate ORANGE DER 8068	422-980-2	187026-95-5	Eye Dam. 1
product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt BROWN JR 547	419-260-5	-	Eye Dam. 1
product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino] benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts; sodium chloride	425-740-5	-	Eye Dam. 1
prosulfocarb (ISO); S-benzyl N, N-dipropylthiocarbamate PROSULFOCARB	401-730-6	52888-80-9	Acute Tox. 4; Skin Sens. 1
pyrazole-1-carboxamidine monohydrochloride	429-520-1	4023-02-3	Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1
pyridaben (ISO); 2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one PYRIDABEN	405-700-3	96489-71-3	Acute Tox. 3
quinclorac (ISO); 3,7-dichloroquinoline-8-carboxylic acid BAS 514 H	402-780-1	84087-01-4	Skin Sens. 1
quizalofop-P-tefuryl (ISO); (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate PANTERA; QUIZALOFOP-P-TEFURYL	414-200-4	119738-06-6	Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2
R, R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate SCH.19927 DIBENZOYLTARTRATE	404-390-7	88976-55-0	Flam. Sol. 1; Skin Sens. 1
R-1-chloro-2,3-epoxypropane (R)-EPICHLOROHYDRIN	424-280-2	51594-55-9	Flam. Liq. 3; Carc. 1B; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1
reaction mas of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt; 7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt SCARLET DER 8107	429-070-4	214362-06-8	Eye Dam. 1
reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate; ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate LATEMUL S-180 A	410-540-2	116726-92-2	Skin Irrit. 2; Skin Sens. 1
reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or 2,6 or 3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride BRAUN HM 2763; BROWN HM 2763; BRUN HM 2763; BRUNO HM 2763	404-540-1	-	Skin Sens. 1
reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5- oxo-2H-2-furylide namino)benzyl)phenyl)pyrrole-2,5-dione DESBIMID	401-970-1	-	Skin Sens. 1
reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy)but-2-ylamine	447-920-2	897393-42-9	Repr. 2; Acute Tox. 4; Skin Corr. 1B; Eye Dam. 1
reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N, N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate C.I. DIRECT YELLOW 166; DIRECT YELLOW 166; GIALLO DIRETTO 166; JAUNE DIRECT 166; MONOAZO YELLOW MA 2822	403-410-1	114565-65-0	Skin Sens. 1
reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate KAYARAD R-825	405-360-6	-	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers ADINE CP 31	401-740-0	-	Acute Tox. 4
reaction mass of 5-heptyl-1,2,4- triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine PK 323	401-940-8	-	Acute Tox. 4; Eye Irrit. 2
reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1) CARTASOL RED K-2BN; RED 10 25 501	408-000-6	118658-98-3	STOT RE 2; Skin Sens. 1
reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide) X 3761	400-930-0	-	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II)to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II) PROJET 780 NP; SUBSTANCE SC101756	407-700-9	101408-30-4	Skin Sens. 1
reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate C.I. DIRECT BLACK 174	400-570-4	162994-84-5	Eye Irrit. 2
reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate HOSTAVIN N 24; SANDUVOR 3050; VP SANDUVOR 3050	400-580-9	85099-50-9	Skin Irrit. 2
reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene PS-6 SENSITIZER	413-840-1	121870-66-4	Self-react. C
reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene; and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6) BROWN JR 543	414-150-3	-	Skin Sens. 1
reaction mass of isomers of branched tetracosane 1-DODECENE DIMER, HYDROGENATED; ALKANE 2	417-060-2	151006-61-0	Acute Tox. 4
reaction mass of isomers of: methyldiphenylmethane; dimethyldiphenylmethane MARLOTHERM L	405-470-4	73807-39-3	Skin Irrit. 2
reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes; di-(2-tetradecyl)naphthalenes; tri-(2-tetradecyl)naphthalenes MCP 968	410-190-0	132983-41-6	Eye Irrit. 2
reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl{](sulfamoyl)[}(sulfonatophthalocyaninato)]copper(II) SUBSTANCE S166075	424-270-8	-	Eye Dam. 1
reaction mass of isomers of: sodium phenethylnaphthalenesulfonate; sodium naphthylethylbenzenesulfonate UNISOL S	405-760-0	-	Eye Dam. 1; Skin Sens. 1
reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene) EMULGATOR SWA; EMULVIN SWA	406-325-8	-	Acute Tox. 4
reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6',13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6', 13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate	430-200-7	-	Eye Dam. 1
reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate); n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate ETHOXYLATED POLYESTER RESIN	405-960-8	-	Skin Sens. 1
reaction mass of O, O'-diisopropyl (pentathio)dithioformate and O, O'-diisopropyl (trithio)dithioformate and O, O'-diisopropyl (tetrathio)dithioformate ROBAC AS/100	403-030-6	137398-54-0	Acute Tox. 4; Skin Sens. 1
reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate MPA	402-090-0	87025-52-3	Skin Corr. 1B
reaction mass of trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate	436-890-6	-	Eye Dam. 1
reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene) EVERSORB 80; TINUVIN 1130; TINUVIN 213	400-830-7	-	Skin Sens. 1
reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid; di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate; di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate; (Z)-3,7-dimethyl-2,6-octadienyl butandioate; ((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid MS6119	415-190-4	-	Skin Sens. 1
reaction mass of: (1'α, 3'α, 6'α)-2,2,3' ,7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane); (1'α, 3'β, 6'α)-2,2,3', 7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane) SPIRAMBRENE	416-930-9	121251-67-0	Skin Irrit. 2
reaction mass of: (1RS, 2RS,3SR, 6RS, 9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS, 2RS, 3RS, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS, 2RS, 4SR, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde	429-860-9	86803-90-9	Skin Sens. 1

Showing 4,001 - 4,200 of 4,691 results.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 03 May 2024. Database contains 4691 unique substances/entries.

Footer Nav Items